Malignant Mixed Salivary Tumor (Carcinosarcoma & Carcinoma ex Pleomorphic Adenoma), from the CureRays guide library.

Malignant mixed salivary tumors are aggressive cancers that arise within or alongside a benign salivary gland tumor; they are treated with surgery plus radiation, with chemotherapy or targeted therapy added for high-risk and advanced disease.

What it is.

Malignant mixed salivary tumors are an uncommon group of aggressive salivary gland cancers that develop in association with a pleomorphic adenoma — the most common benign salivary tumor (a 'mixed' tumor of gland and connective-tissue elements). The most frequent type is carcinoma ex pleomorphic adenoma, in which a cancer grows out of a pre-existing benign mixed tumor, often one that has been present for years. A rarer type is true carcinosarcoma, which contains both cancerous gland (carcinoma) and cancerous connective-tissue (sarcoma) components. These cancers usually arise in the parotid gland (in front of the ear) but can occur in the submandibular or minor salivary glands. A long-standing salivary lump that suddenly grows, becomes painful, or affects the facial nerve is a warning sign. Because they can spread along nerves and to lymph nodes and distant organs, they are treated aggressively with surgery and radiation, and the outlook depends heavily on how far the cancer has grown beyond the original benign tumor.

How radiation treats it.

Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while healthy cells repair themselves more effectively. For malignant mixed salivary tumors, radiation after surgery treats the microscopic cancer left behind — including disease that travels along nerves — improving the chance the cancer does not return. It is delivered as a series of short, painless daily sessions; standard external-beam, proton, and neutron treatments leave no radioactivity in your body, so you remain safe to be around family and children throughout treatment.

The ways we can treat it.

Intensity-modulated radiation therapy (IMRT). Computer-shaped beams deliver a high dose to the tumor bed and at-risk nerves and lymph nodes while sparing the spinal cord, opposite salivary glands, and swallowing structures.

Neutron or proton therapy. For tumors that resist standard radiation or sit near critical structures, particle-beam therapy (neutrons or protons) can deliver more effective or more precisely shaped dose.

Radiation along nerve pathways. When the cancer spreads along nerves (perineural invasion), the radiation field is extended to follow the involved nerve and treat microscopic disease tracking away from the main tumor.

Questions we hear often.

I had a salivary lump for years — why is it cancer now? The most common type, carcinoma ex pleomorphic adenoma, develops when a cancer grows out of a long-standing benign salivary tumor. That is why a lump that was stable for years but suddenly grows, hurts, or affects the face should be evaluated promptly.

Will my face be affected? Parotid tumors sit near the facial nerve, which controls movement of the face. Surgeons work to preserve the nerve when possible, but if the cancer involves it, function can be affected. Your team will discuss this and options for rehabilitation before surgery.

Does the type of tumor change my outlook? Yes. A minimally invasive carcinoma ex pleomorphic adenoma can have an excellent outlook, while widely invasive tumors and true carcinosarcomas are more aggressive. How far the cancer extends beyond the original benign tumor is one of the most important factors, and your pathology report helps guide treatment.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.